RHUMBLINE ADVISERS – Vertex Pharmaceuticals Incorporated Transaction History
RHUMBLINE ADVISERS portfolio value:
$118.18M
portfolio value
RHUMBLINE ADVISERS quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.08% | 12.18K shares | 6.59M | $289.54 | 408.18K |
| Q2 2022 | share | Increase | +4.40% | 16.67K shares | 12.59M | $281.79 | 395.99K |
| Q1 2022 | share | Decrease | -3.30% | -12.95K shares | 12.84M | $260.97 | 379.31K |
| Q4 2021 | share | Increase | +1.81% | 6.99K shares | 16.25M | $222.45 | 392.26K |
| Q3 2021 | share | Decrease | -3.86% | -15.48K shares | -10.91M | $181.39 | 385.27K |
| Q2 2021 | share | Decrease | -20.90% | -105.89K shares | -28.06M | $201.63 | 400.75K |
| Q1 2021 | share | Decrease | -2.99% | -15.60K shares | -14.55M | $214.89 | 506.64K |
| Q4 2020 | share | Increase | +0.45% | 2.34K shares | -18.04M | $236.34 | 522.25K |
| Q3 2020 | share | Decrease | -2.38% | -12.65K shares | -13.13M | $272.12 | 519.90K |
| Q2 2020 | share | Increase | +5.67% | 28.57K shares | 34.68M | $290.31 | 532.56K |
| Q1 2020 | share | Increase | +0.47% | 2.34K shares | 10.08M | $237.95 | 503.98K |
| Q4 2019 | share | Decrease | -1.84% | -9.39K shares | 23.25M | $218.95 | 501.64K |
| Q3 2019 | share | Increase | +5.03% | 24.49K shares | -2.64M | $169.42 | 511.03K |
| Q2 2019 | share | Increase | +1.20% | 5.76K shares | 783K | $183.38 | 486.54K |
| Q1 2019 | share | Increase | +5.80% | 26.36K shares | 13.13M | $183.95 | 480.78K |
| Q4 2018 | share | Increase | +1.43% | 6.41K shares | -11.04M | $165.71 | 454.41K |
| Q3 2018 | share | Decrease | -1.13% | -5.11K shares | 9.33M | $192.74 | 448.00K |
| Q2 2018 | share | Increase | +2.91% | 12.82K shares | 5.25M | $169.96 | 453.11K |
| Q1 2018 | share | Decrease | -1.71% | -7.64K shares | 4.63M | $162.98 | 440.29K |
| Q4 2017 | share | Increase | +4.79% | 20.47K shares | 2.13M | $149.86 | 447.93K |
| Q3 2017 | share | Increase | +1.46% | 6.13K shares | 10.69M | $152.04 | 427.45K |
| Q2 2017 | share | Increase | +0.67% | 2.79K shares | 8.53M | $128.87 | 421.32K |
| Q1 2017 | share | Increase | +0.66% | 2.75K shares | 15.13M | $109.35 | 418.52K |
| Q4 2016 | share | Increase | +4.48% | 17.83K shares | -4.07M | $73.67 | 415.76K |
| Q3 2016 | share | Increase | +5.53% | 20.84K shares | 2.26M | $87.21 | 397.92K |
| Q2 2016 | share | Increase | +4.55% | 16.40K shares | 3.76M | $86.02 | 377.08K |
| Q1 2016 | share | Increase | +3.98% | 13.79K shares | -14.97M | $79.49 | 360.68K |